1. Nunes T, Rocha JF, Falcao A, Almeida L, Soares-da-Silva P (2013) Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers. Epilepsia 54:108–116.
https://doi.org/10.1111/j.1528-1167.2012.03595.x
2. AAP News (2016) Food and Drug Administration update, 6 April 2016.
http://www.aappublications.org/news/2016/04/06/FDAUpdate040616
. Accessed 25 Aug 2017
3. Mehrotra S (2016) Quantitative analysis to support full extrapolation of efficacy in children for partial onset seizures in adjunctive setting: FDA-PEACE initiative, January 2016.
http://pharmacy.umaryland.edu/media/SOP/wwwpharmacyumarylandedu/centers/cersievents/pedsextrapolation/mehrotra-presentation-notes.pdf
. Accessed 5 May 2017
4. Men AY (2015) Assessing quality and quantity of data to establish exposure-response similarity between adults and pediatric patients: PEACE initiative, January 2015.
https://www.pharmacy.umaryland.edu/media/SOP/wwwpharmacyumarylandedu/centers/cersievents/pediatricpbpk/Men%20-%20PEACE%20Initiative.pdf
. Accessed 5 May 2017
5. Pellock JM, Carman WJ, Thyagarajan V, Daniels T, Morris DL, D’Cruz O (2012) Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review. Neurology 79:1482–1489.
https://doi.org/10.1212/WNL.0b013e31826d5ec0